Unlock stock picks and a broker-level newsfeed that powers Wall Street.
23.69
-2.67
(-10.13%)
At close: April 3 at 4:00:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-194,501
-194,501
-102,826
-153,085
-128,946
Investing Cash Flow
-404,077
-404,077
139,886
20,519
-99,835
Financing Cash Flow
608,851
608,851
4,192
152,999
250,280
End Cash Position
126,050
126,050
115,777
74,525
54,092
Interest Paid Supplemental Data
206
206
162
179
158
Capital Expenditure
-12,838
-12,838
-34,480
-2,836
-1,597
Issuance of Capital Stock
596,619
596,619
--
149,825
243,106
Repayment of Debt
-1,576
-1,576
-76
-1,130
-849
Free Cash Flow
-207,339
-207,339
-137,306
-155,921
-130,543
12/31/2021 - 8/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRIX Nurix Therapeutics, Inc.
10.51
-7.64%
RVMD Revolution Medicines, Inc.
32.87
-5.00%
BPMC Blueprint Medicines Corporation
87.11
-3.22%
IDYA IDEAYA Biosciences, Inc.
15.57
-4.77%
NUVL Nuvalent, Inc.
68.32
-3.04%
RLAY Relay Therapeutics, Inc.
2.2900
-8.03%
ARVN Arvinas, Inc.
6.90
-3.90%
BCYC Bicycle Therapeutics plc
7.43
-7.70%
CGEM Cullinan Therapeutics, Inc.
7.49
-4.22%
RYTM Rhythm Pharmaceuticals, Inc.
49.82
-4.12%